Comparison of Plasma Metabolites From Patients With Non-Small Cell Lung Cancer by Erlotinib Treatment and Skin Rash

Erlotinib is a necessary anticancer treatment for non-small cell lung cancer (NSCLC) patients yet it causes severe side effects such as skin rash. In this study, researchers compared the untargeted compound profiles before and after erlotinib administration to observe changes in blood metabolites in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Won Kil, Myong, Jisoo, Kwag, Eunbin, Shin, Younmin, Son, Ji Woong, Yoo, Byong Chul, Kim, Byoung-Soo, Yoo, Hwa-Seung, Choi, Jeong June
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524077/
https://www.ncbi.nlm.nih.gov/pubmed/37750513
http://dx.doi.org/10.1177/15347354231198090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524077/
https://www.ncbi.nlm.nih.gov/pubmed/37750513
http://dx.doi.org/10.1177/15347354231198090

Ejemplares similares